We here present an immunologic head-to-head comparison between human umbilical cord lining mesenchymal stem cells (clMSCs) and adult bone marrow MSCs (bmMSCs) from patients >65 years of age. clMSCs had significantly lower HLA class I expression, higher production of tolerogenic TGF-β and IL-10, and showed significantly faster proliferation. In vitro activation of allogeneic lymphocytes and xenogeneic in vivo immune activation was significantly stronger with bmMSCs, whereas immune recognition of clMSCs was significantly weaker. Thus, bmMSCs were more quickly rejected in immunocompetent mice. IFN-γ at 25 ng/ml increased both immunogenicity by upregulation of HLA class I/ HLA-DR expression and tolerogenicity by increasing intracellular HLA-G and surface HLA-E expression, augmenting TGF-β and IL-10 release, and inducing indoleamine 2,3-dioxygenase (IDO) expression. Higher concentrations of IFN-γ (>50 ng/ml) further enhanced the immunosuppressive phenotype of clMSCs, more strongly downregulating HLA-DR expression and further increasing IDO production (at 500 ng/ml). The net functional immunosuppressive efficacy of MSCs was tested in mixed lymphocyte cultures. Although both clMSCs and bmMSCs significantly reduced in vitro immune activation, clMSCs were significantly more effective than bmMSCs. The veto function of both MSC lines was enhanced in escalating IFN-γ environments. In conclusion, clMSCs show a more beneficial immunogeneic profile and stronger overall immunosuppressive potential than aged bmMSCs.
INTRODUCTION
tiple mechanisms, requiring dynamic cross-talk between MSCs and immune cells and involving soluble immunomodulatory factors, cause a shift of the immune re-Mesenchymal stem cells (MSCs) have been identified a promising cell population not only for tissue regenera-sponse towards tolerance or anergy (11, 28, 46) . Release of transforming growth factor-β (TGF-β), hepatocyte tion (15, 30, 40) , but also for immunomodulatory therapy (31, 42 ). An emerging body of data indicates that MSCs growth factor (HGF), and induction of the tryptophan catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) may play specific roles as immunomodulators in maintenance of peripheral tolerance, transplantation tolerance, has been suggested to mediate the immunosuppressive effects of MSCs (9, 22) . autoimmunity, and tumor immunobiology (25) . MSCs were shown to interact with various immune cell types
The immunosuppressive properties of MSCs have been examined in a variety of animal models of autoim-including T cells (9,18,41), B cells (1, 7, 11) , dendritic cells (DCs) (14, 48) , and natural killer (NK) cells (17, 37) . Mul-munity, solid organ, or stem cell transplantation. MSCs 656 DEUSE ET AL.
have been reported to ameliorate experimental autoim-flushed from femoral heads and isolated using plastic adherence. Cells were grown in their specific growth mune encephalomyelitis (46, 47) in mice. Infusion of host-derived MSCs has been shown to decrease the re-media [CMRL-1066 + antibiotics + L-glutamine (Cell ResearchCorp) for clMSCs and mesenchymal stem cell jection of allogeneic bone marrow (BM) stem cells in a murine transplant model (26) . Even more impressive, growth media (Promocell) for bmMSCs]. Cells were split at a confluency of 80-85% by mechanically lifting MSC administration sufficiently reversed ongoing graft versus host disease (GVHD) (45) in mice, an effect that the cells from the tissue culture plastic surface using a cell lifter (Costar, Corning). Before transplantation, could already be verified in human disease (19, 33) . Modest success in prolonging the survival of allogeneic MSCs were dissociated by collagenase type I solution at a concentration of 0.025% for 5 min at 37°C, and skin transplants by MSC infusion has already been demonstrated in baboons (3) . However, controversies exist resuspended in sterile PBS at 1 × 10 6 cells per 50 µl.
MSC viability was approximately 95% as determined by on the efficiency of MSC infusion to prolong solid organ graft survival (13, 50) . The involved mechanisms of trypan blue staining. MSC transplantation was performed by direct injection of 1 × 10 6 MSCs into the right MSC-based immunomodulation may favor the suppression of a more generalized state of immune activation in gastrocnemius muscle of recipient mice using a 27gauge syringe. In vitro experiments with MSCs were BM transplant, GVHD, or autoimmune disease compared to the more localized immune response in organ also performed at a confluency of 80-85%. transplantation (2) . Still, recommendations have been Multipotent Capacity formulated on how to move MSC-based tolerance strate-Adipogenic Differentiation. Cells were plated onto gies forward toward clinical application in solid organ 24-well plates at 6 × 10 4 cells per well (3.15 × 10 4 cells/ transplantation (8).
cm 2 ) and differentiation was induced at 80-90% conflu-Because MSCs can be isolated from various tissues ency by using mesenchymal stem cell adipogenic differincluding BM, adipose tissue (51), umbilical cord (34), entiation medium (Promocell) for 14 days at 37°C and placenta, liver, and spleen (4), and these cell populations 5% CO 2 . Medium was changed every third day. After 2 may vary in their functional capacities, the optimal weeks, cells were washed with PBS (Gibco) and fixed source of MSCs for cell-based immunomodulatory therusing 10% formalin for 30 min at room temperature. apies remains to be determined. Patients in need of stem The Oil Red O stock solution was freshly prepared by cell-based therapies for cardiovascular diseases are usudissolving 300 mg Oil Red O in 100 ml 99% isopropaally aged and approaches using autologous adult stem nol. Fixed cells were washed with distilled water cells have to deal with aged cells. Allogeneic stem cell (Gibco), incubated with isopropanol for 5 min followed strategies can utilize fetal stem cells, but may encounter by incubation with filtered Oil Red O working solution problems with immune activation and cell rejection. We for 5 min. Hematoxylin stain was added for 30 s, folhere present an immunologic head-to-head comparison lowed by 1% acetic acid. Lipids appear red and nuclei between human umbilical cord lining MSCs (clMSCs) appear blue on a phase contrast microscope. and aged adult BM MSCs (bmMSCs) to help clarify Chondrogenic Differentiation. Cells (5 × 10 5 ) were which strategy offers better immunomodulatory properplated into a 96-well U-bottom suspension culture plate ties.
using ready-to-use mesenchymal stem cell chondrogenic MATERIALS AND METHODS differentiation medium (Promocell) in an incubator with an atmosphere of 5% CO 2 at 37°C. Spheroids spontane-Animals ously formed within 24-48 h. Cells were incubated for Six-to 8-week-old male Balb/c and Scid-beige 21 days; medium was changed every third day without (CB17.Cg-Prkdc scid Lyst bg /Crl) mice were purchased aspirating the spheroids. from Charles River Laboratories (Sulzfeld, Germany) Spheroids were placed into 10% formalin for 1 h, and received humane care in compliance with the Guide dehydrated, and paraffin embedded. Paraffin sections (5 for the Principles of Laboratory Animals. µm) were prepared, and slides were deparaffinized, hy-MSC Culture and Cell Transplantation drated, and stained with toluidine blue (1 g toluidin blue in 100 ml 70% ethanol) for 3 min. Slides were dehy-Female neonatal clMSCs (kindly provided by Cell drated through 95% and 100% ethanol, and cleared in Research Corporation Pte Ltd, Singapore) were isolated xylene. Chondrogeneic spheroids appear blue on a phase from the outer amniotic lining of the umbilical cord and contrast microscope. were cultured in PTT4 media (CellResearch). bmMSCs were isolated from the bone marrow of three different Osteogenic Differentiation. Cells (6 × 10 4 ) were plated onto a 24-well tissue culture plate (3.15 × 10 4 healthy female donors more than 65 years of age (Promocell, Heidelberg). Therefore, the bone marrow was cells/cm 2 ) and differentiation was induced after cells reached >100% confluency (after 24-72 h) in an incuba-stripped using restore Western blot stripping buffer (Pierce) for 15 min at room temperature. Membranes tor at 37°C and 5% CO 2 . Cells were incubated with mesenchymal stem cell osteogenic differentiation medium were blocked for 2 h using in 5% BSA/TPBS buffer, and primary antibody for GAPDH was added overnight (Promocell) for 21 days; medium was changed every third day. Cells were fixed by removing the media, at 4°C. washing with PBS, and incubating with 10% formalin Bioluminescence Imaging (BLI) for 10 min. Alizarin Red S solution (2 g Alizin red S in 100 ml dest. water) was incubated for 2 min. The os-BLI is a noninvasive, molecular imaging modality that allows for quantitative and repetitive imaging of tar-teogenic lineage was identified by dark red staining on a phase contrast microscope.
geted cells, transfected with plasmid vectors encoding for firefly luciferase (Fluc), in living organisms (44). In MSC Proliferation Assay the presence of ATP and O 2 , Fluc converts exogenously administered D-luciferin to the optically active metabo-MSCs were seeded in 24-well plates (3,000 cells/ well) and grown in their specific growth media. Daily lite oxyluciferin. Light emission can be monitored with an ultrasensitive CCD camera. In the setting of cell cell counts were determined using the CellTiter 96 Cell Aqueous One Solution Proliferation Assay (Promega, transplantation, BLI signals correlate with the number of living Fluc + cells. For this study, MSCs were trans-Madison, WI). Triplicates were performed and the absorbance at 490 nm was measured with the Magellan duced with Adv-Fluc (CMV) at a multiplicity of infection of 10 to stably express Fluc. Briefly, after MSCs ELISA Reader and Software (Tecan Systems Inc, San Jose, CA).
were seeded, viral aliquots were added to 0.75 ml of their cell-specific growth media containing 8 µg/ml po-TGF-β and IL-10 Elispot Assays lybrene at a multiplicity of infection of 10, and the plate was then placed into a cell incubator at 37°C and 5% The cytokine release for TGF-β and IL-10 was analyzed using human Elispot assays (R&D Systems). CO 2 for 24 h. Medium was changed after 24 h. Transduction efficacy was confirmed using Adv-GFP. clMSCs or bmMSCs (5 × 10 5 ) were plated in their cellspecific growth media onto TGF-β and IL-10-coated BLI was performed using the Xenogen in vivo imaging system (Caliper Life Sciences, Hopkinton, MA) Elispot plates for 48 h in an incubator at 37°C and 5% CO 2 .
as reported previously (5) . Mice were anesthetized with 2% isoflurane and D-luciferin (Caliper Life Sciences) Spot developing was performed according to the manufacturer's protocol (BD Biosciences). Spots were was administered IP at a dose of 375 mg/kg of body weight. At the time of imaging, animals were placed in automatically enumerated using an Elispot plate reader (CTL, OH) for scanning and analyzing. a light-tight chamber, and photons emitted from FLucexpressing MSCs were counted. The recipient mice IDO Western Blots were scanned repetitively on days 0, 1, and then every other day until the signal dropped into the background. Cell extract was prepared in RIPA buffer (Sigma). Amount of protein was determined and electrophoresis BLI signals were quantified in units of photons per second (total flux) and are presented on a logarithmic scale. was performed by loading an 8 µg protein sample into each well. Proteins were then blotted onto PVDF mem-Cell Surface Molecule Expression brane in transfer buffer (3.75 g glycin, 7.25 g Tris base, 2.5 ml methanol was dissolved in total 2.5 L). The mem-MSCs grown in their growth media with or without additional recombinant human IFN-γ at 25 ng/ml (low-branes were incubated in 5% BSA/TPBS solution prepared in PBST buffer (1× PBS, pH 7.0, 1 ml Tween-20/ dose; PeproTech) were harvested to assess their expression of various surface markers. Cells were dissociated L) at room temperature for 2 h and then primary antibodies were added overnight at 4°C in 1:5000 dilution by collagenase type I solution at a concentration of 0.025% for 5 min at 37°C, and 5 × 10 5 cells were stained for IDO. Once the primary antibody labeling was performed, the blots were washed with PBST and the sec-for 45 min at 4°C in 100 µl of 0.1% BSA in PBS containing an appropriate dilution of a desired PE-conju-ondary antibody labeling (goat anti-mouse conjugated to horseradish peroxidase) was performed at room temper-gated antibody. Primary PE-conjugated antibodies (all BD Bioscience unless stated otherwise) used were anti-ature for 1 h at 1:5000 dilution in 5% BSA in PBST. The High-IFN-γ Veto Function of MSCs (clone 5C3), CD80 (clone L307.4), and CD86 (clone MSCs grown in their growth media with or without 2331). IgG3 (clone 133316) isotype control was puradditional recombinant human IFN-γ at 25 ng/ml (low chased from R&D Systems (Minneapolis, MN), IgG2a dose) or 500 ng/ml (high dose). Cells were harvested to isotype control from Abcam (clone MOPC-173; Camassess their surface expression of HLA class I, HLAbridge, MA), IgG1 (clone MOPC-21), and IgM (clone DR, HLA-G, and HLA-E by flow cytometry as de-G155-228) from BD Biosciences. For the detection of scribed above. Also, their IDO production was quantiintracellular HLA-G, cells were made permeable using fied in Western blot assays. the fix and perm cell permeabilization kit (BD Bioscience).
Statistical Analysis Flow cytometry was performed on a FACSCalibur
Data are presented as mean ± SD. Comparisons besystem with Cell Quest Pro software (Becton Dickinson, tween two groups were done by independent sample t-Heidelberg, Germany); 10,000 events were collected.
tests. Comparisons between groups were done by analy-Analysis of data was performed using Flowjo (Tree Star, sis of variance between groups (ANOVA) with LSD Ashland, OR). In the histograms, the isotype controls Post Hoc tests. Differences were considered significant are represented by the gray solid areas and the antigens for p < 0.05. Statistical analysis was performed using of interest by solid lines. Mean fluorescence intensities SPSS statistical software for Windows (SPSS, Chicago, (MFI) were calculated. Molecule expression is defined IL). as the ratio (MFI of antigen)/(MFI of negative isotype RESULTS control), with 1 equaling no expression.
Phenotypic and Functional Characteristics of MSCs Elispot Assays
Both clMSCs and bmMSCs were positive for the The cellular in vivo immune responses in Balb/c mesenchymal stem cell markers CD90 and CD105 and mice were studied after cell transplantation of either negative for hematopoietic stem cell markers such as clMSCs or bmMSCs. The spleen of recipient animals CD34, CD45, and CD117 ( Fig. 1A ). They were positive was harvested 5 days after MSC transplantation to isofor the cell-cell interaction protein CD44 and negative late recipient splenocytes. Elispot assays using 5 × 10 5 for CD31. Both MSC lines were mildly positive for mitomycin-inhibited MSCs (Sigma Aldrich, St. Louis, SSEA-4, an embryonic stem cell marker, and remained MO) as stimulator cells and 5 × 10 6 recipient splenonegative for SSEA-1, a marker for maturity, and the kercytes as responder cells were performed according to the atan sulfate antigen TRA-1-60, a human embryonic carmanufacturer's protocol (BD Biosciences) using IFN-γ cinoma marker. and IL-4-coated plates.
In culture, both clMSCs and bmMSCs had fibroblast-The immunogenicity of MSCs to elicit an in vitro like spindle-shaped morphology (Fig. 1B) , although immune response was investigated by incubating 1 × 10 5 clMSCs were mildly bigger. After trypsination, the clMSCs or bmMSCs with 1 × 10 6 human peripheral rounded clMSCs had diameters of 15.8 ± 3.1 µm and blood mononuclear cells (PBMCs) for 7 days on a the bmMSCs of 11.8 ± 4.1 µm (p < 0.001). Both MSC coated Elispot plate. Human PBMCs from healthy dolines were easily differentiable towards the chondronors were previously isolated by Ficoll gradient centrifugenic, adipogenic, and osteogenic lineages. No differgation.
ences between both MSC lines were noted regarding the The immunosuppressive properties of MSCs in vitro time required for cell differentiation. were assessed by their potential to suppress a one-direc-When grown in their cell specific media, cell prolifertional allogeneic mixed lymphocyte response in an alloation of clMSCs was much faster than of bmMSCs ( Fig.  geneic setting. Mitomycin-inhibited stimulator lympho-1C). Differences between groups were statistically sigcytes (1 × 10 5 , freshly isolated from healthy donors by nificant (p < 0.05) for day 3 and later time points. Thus, Ficoll) and 1 × 10 6 allogeneic effector lymohocytes were cell cultures with clMSCs required splitting approxiincubated with 1 × 10 5 clMSCs or bmMSCs in an IFNmately every 3 days, whereas bmMSCs were split on γ, IL-4, or IL-2-coated Elispot plate for 7 days. Plates average every 10 days. were developed according to the manufacturer's proto-Antigeneic, Costimulatory, and Tolerogenic Properties col (BD Bioscience) and spots were automatically enuof MSCs merated using an Elispot plate reader (CTL, OH) for scanning and analyzing.
MSCs were screened for their surface expression of HLA antigens, costimulatory factors, and immune toler-For IL-2 Elispots, clMSCs and bmMSCs were used ance molecules at rest and in an inflammatory milieu surface expression of HLA-E (p = 0.012 for clMSCs and p = 0.033 for bmMSCs), but not HLA-G (not with IFN-γ at 25 ng/ml. clMSCs had far lower expressions of HLA class I molecules (p < 0.001) and β 2 -shown) was significantly upregulated with IFN-γ in both MSC lines. Intracellular HLA-G, however, was constitu-microglobulin (p = 0.001) than bmMSCs. Both MSCs completely lacked HLA-DR expression and were nega-tively expressed in both MSCs, although at higher levels in clMSCs (p = 0.034). HLA-G was upregulated by IFN-tive for the costimulatory factors CD40, CD80, and CD86 ( Fig. 2A ). After stimulation with IFN-γ, the levels γ (p = 0.005 for clMSCs and p = 0.043 for bmMSCs). The release of the tolerogenic cytokines TGF-β and of HLA class I (p = 0.014 and p = 0.015) and HLA-DR (p < 0.001 each) significantly increased for clMSCs and IL-10 was quantified in Elispot assays. At rest, both MSC lines produced TGF-β, but only clMSCs released bmMSCs, respectively. All costimulatory factors remained negative after IFN-γ challenge. Interestingly, detectable amounts of IL-10 ( Fig. 2B) . After IFN-γ stim- ulation, the release of both TGF-β (p = 0.018 and p = Immunogenicity of MSCs 0.003) and IL-10 (p < 0.001 and p < 0.001) was significantly increased by clMSCs and bmMSCs, respectively.
Because clMSCs and bmMSCs were shown to have differences in their expression of immunogenic mole-Absolute values for TGF-β and IL-10 release were significantly higher in clMSC cultures (p = 0.03 and p < cules as well as in their release of tolerogenic factors, it was tested if they were immunogenic enough to elicit an 0.001, respectively) than with bmMSCs. IDO expression was hardly detectable in resting MSCs, but was strongly immune response in vivo and in vitro. In preparation for BLI, clMSCs and bmMSCs tolerated the FLuc transduc-upregulated by IFN-γ in clMSCs (p < 0.001) and bmMSCs (p = 0.041) (Fig. 2C) . tion well and both showed a high transduction efficacy of >95% as confirmed by Adv-GFP/DAPI double stain-HLA-E surface expression was already significantly upregulated by 25 ng/ml IFN-γ and remained at similar ing (not shown).
Elispot assays, performed 5 days after xenogeneic levels in higher IFN-γ milieus.
With increasing IFN-γ concentrations from 25 to 500 MSC transplantation, showed that both MSC lines triggered some cellular immune activation. However, bmMSCs ng/ml, IDO expression further significantly increased from 1.2 ± 0.1 to 2.3 ± 0.1 (p < 0.001) in clMSCs ( Fig.  were much more immunogenic and the provoked Th1 and Th2 responses were much stronger. Spot frequen-4B). No significant differences were observed between 25 and 100 ng/ml IFN-γ in clMSCs and throughout the cies for IFN-γ and IL-4 were 10.8-fold (95% CI: 6.6-17.8) and 3.4-fold (95% CI: 2.2-5.2) higher with bmMSCs, IFN-γ range in bmMSCs.
To test their net immunosuppressive effects, MSCs respectively (p < 0.001 each vs. clMSCs) (Fig. 3A) . Concordantly, bmMSCs were rejected more quickly were incubated with allogeneic mixed PBMC cultures at different IFN-γ concentrations. Stimulator and effector than clMSCs in immunocompetent Balb/c mice. BLI signals dropped into the background after 7.2 ± 0.9 days lymphocytes had three out of four possible HLA-A/B mismatches and one out of two possible HLA-DR mis-for bmMSCs and after 10.9 ± 1.2 days for clMSCs (p < 0.001) (Fig. 3B) . In immunodeficient SCID-beige mice, matches ( Table 1 ). Effector lymphocyte activation was assessed by IL-2 Elispot assays ( Fig. 4C ). Both clMSCs cell survival was prolonged and similar (14.7 ± 2.5 and 17.0 ± 2.8 days, respectively, p = 0.205).
(p < 0.001) and bmMSCs (p < 0.001) significantly reduced the IL-2 spot frequencies of mixed PBMC cul-Allogeneic immune activation was assessed in Elispot assays after incubation of MSCs with human PBMCs.
tures in the absence of IFN-γ, although clMSCs were significantly more potent that bmMSCs (p < 0.001). Both MSC lines showed five out of six possible HLA-A, HLA-B, and HLA-DR mismatches with the used ef-Efficacy of bmMSCs was significantly improved in a low-dose IFN-γ environment (25 ng/ml; p < 0.001) and fector lymphocytes, but all cells shared the HLA-A24 epitope ( Table 1) . We found only very weak in vitro T-IL-2 spots were significantly lower with 500 versus 25 ng/ml IFN-γ in both MSCs (p < 0.001 each). cell activation by clMSCs (PBMC + clMSC) with nonsignificant increases in IFN-γ spots (ANOVA p = 0.002, DISCUSSION LSD post hoc p = 0.419) and IL-2 spots (ANOVA p = 0.042, LSD post hoc p = 0.060) versus PBMC control.
There are fundamental biological and practical differences between clMSCs and bmMSCs for cell-based im-Allogeneic in vitro lymphocyte activation, however, was stronger for bmMSCs (PBMC + bmMSC) with signifi-munomodulation. Whereas bmMSCs can be individually tailored for autologous use in chronic diseases, the re-cantly increased IFN-γ (LSD post hoc p = 0.001) and IL-2 spots (LSD post hoc p = 0.014) ( Fig. 3C ) versus trieval of sufficient amounts of multipotent cells from BM of aging patients becomes increasingly problematic. PBMC.
These data demonstrate that although both clMSCs Individualized cell production and storage would be very costly. On the other side, clMSCs are abundantly and bmMSCs are recognized by allogeneic and xenogeneic lymphocytes, clMSCs are less immunogenic, cause available, and can easily be isolated and expanded for a commercial off-the-shelf product for allogeneic use. The less immune activation, and get rejected more slowly. effect of MSCs seems not to be donor restricted, because Immunosuppressive Properties of MSCs the survival of third-party grafts could also be prolonged and third-party MSCs have also been shown to alleviate HLA molecule expression of MSCs was further assessed in escalating IFN-γ environments. Although both the rejection of skin grafts in baboons (3) . MSCs were shown to modulate mixed lymphocyte reactions inde-clMSCs and bmMSCs upregulated HLA-DR expression upon low-dose IFN-γ stimulation at 25-50 ng/ml, HLA-pendent of MHC matching status (20) and third-party MSCs were shown to facilitate engraftment after umbili-DR was downregulated again with higher doses (100-500 ng/ml) (Fig. 4A) . Throughout the IFN-γ range of cal cord blood transplantation (16) . Third-party MSC infusion in hematopoietic stem cell transplant patients did 25-500 ng/ml, HLA-DR expression and HLA-I expression were significantly lower in clMSCs compared to not induce immunological memory to the infused MSCs (39). These characteristics support the possibility of ex-bmMSCs (p ≤ 0.020). Although HLA-I expressions also showed mild reductions with increasing IFN-γ concen-ploiting universal "one cell fits all" MSC lines for therapeutic applications. trations, the downregulation remained statistically insignificant for both clMSCs and bmMSCs. Intracellular Both clMSCs and bmMSCs used in our study met phenotypical and functional criteria required for the def-HLA-G showed a mild increase with rising IFN-γ that reached significance for the 500 ng/ml concentration inition of MSCs (12,25). They express CD105, CD90, and CD44, and are devoid of hematopoietic and endo-compared to unstimulated conditions in both cell lines. demonstrated that bmMSCs were much more immunogenic than clMSCs (A; †p < 0.01). Survival of FLuc + MSCs in Balb/c mice and in SCID-beige mice was longitudinally followed by BLI (B). bmMSCs were rejected more quickly than clMSCs in immunocompetent Balb/c mice, whereas MSC survival was similar and significantly longer in immunodeficient SCID-beige mice. Allogeneic immune activation in vitro after incubation of MSCs with human PBMCs showed very weak T-cell activation by clMSCs but a significant lymphocyte activation by bmMSCs (C; *p < 0.05, †p < 0.01). thelial markers, such as CD31, CD34, CD45, and found at least mild immune activation with all MSC lines tested in our lab so far. However, MSCs gain toler-CD117. Because of the lack of specific MSC markers, additional antigens like the glycolipids SSEA-1 and ogenic potential through IDO expression (22) , HLA-G production (24) , and IL-10 and TGF-β secretion (23) . SSEA-4 as well as the keratin sulfate TRA-1-60 are usually screened for. In line with previous reports (10,32), These properties firstly alleviate immune recognition and diminish MSCs rejection and secondly may be used both of our MSC lines were positive for the embryonic stem cell-associated marker SSEA-4, although contrary to suppress ongoing immune processes in the close vicinity of the administered or homed MSCs. We show findings were reported (36).
Additionally, clMSCs and bmMSCs allowed adipo-that clMSCs produce larger amounts of tolerogenic IL-10 and TGF-β and have higher amounts of intracellular geneic, osteogeneic, and chondrogeneic differentiation in vitro. Neither clMSCs nor bmMSCs were positive for HLA-G. IFN-γ dose-dependently exerts opposing effects on Oct4, Sox-2, or TRA-1-60 (data not shown), essential factors for maintenance of pluripotency and reflecting MSCs, enhancing their immunogenicity at low doses and increasing the production of tolerogenic cytokines the primitiveness of embryonic stem cells (21, 49) . Even after serum deprivation, we and others (49) could not and the expression of IDO at higher doses (6) . It was previously shown that low-dose IFN-γ is produced by induce Oct4 expression, as has been reported earlier (27) . In accordance with previous reports on osteogenic untreated MSCs, which may serve as endogenous autocrine stimulation (6) to enable their APC function. Dur-capacity of stem cells (49) , we could show the far superior proliferation capacity of clMSCs over adult ing inflammation, GVHD, and immune rejection, high levels of inflammatory mediators like IFN-γ are hypoth-bmMSCs.
Our data show that MSCs may be considered hypo-esized to create a microenvironment in which the veto properties of MSCs dominate and MSCs suppress the immunogenic due to their relatively low MHC I expression, but they are not intrinsically immunoprivileged and ongoing immune reaction (6, 29) . We show that repression of HLA-DR is much more effective than of HLA-I undergo immune rejection in an immunocompetent host. The reduction in MSC survival times between immuno-in both clMSCs and bmMSCs. Head-to-head comparison between MSC lines shows that upregulated HLA-deficient SCID-beige mice and Balb/c mice must be attributed to host immune responses. We show that DR expression by 25 ng/ml IFN-γ remains much lower in clMSCs, and that HLA-DR downregulation by IFN-γ clMSCs express significantly lower levels of HLA-I at rest and after stimulation with IFN-γ. Recent evidence at concentrations beyond 50 ng/ml is also more effective in clMSCs. IDO production increases with rising IFN-γ, indicates that MSCs can function as antigen presenting cells (APC) themselves, with phagocytic function and and shows no decrease at higher concentrations. The net immunosuppressive effect of MSCs was the ability to induce T-cell responses (6, 38) . We demonstrate that, under resting cell culture conditions, both tested in mixed PBMC cultures. The main findings are that clMSCs are more immunosuppressive than bmMSCs MSCs were negative for HLA-DR. In the presence of IFN-γ, however, HLA-DR was upregulated, especially in the absence of IFN-γ and that the immunosuppressive effect of MSCs can be enhanced by IFN-γ. In an inflam-in bmMSCs, in which significantly higher expression values were achieved compared to clMSCs. Because cell matory milieu, MSCs seem to get further activated, culture conditions can impact HLA-DR expression (35) , all experiments were performed at similar cell densities. Both MSC lines were negative for costimulatory mole- 
